archive-com.com » COM » N » NEXTECHINVEST.COM

Total: 35

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Team | D Livingston | Nextechinvest
    board of scientific advisors of the U S National Cancer Institute a member of the Institute of Medicine of the National Academy of Sciences and its Institute of Medicine USA among other such bodies and a consultant to numerous oncology companies Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland P 41

    Original URL path: http://www.nextechinvest.com/en/team/d-livingston.html (2016-04-26)
    Open archived version from archive


  • Team | K Altmann | Nextechinvest
    Chemistry member of the Pharma Research Management Board and head of the Scientific Chemistry Council Novartis Ltd and serves as a consultant to several pharmaceutical companies Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland P 41 0 44 366 66 11 F 41 0 44 366 66 10 Newsletter Registration Please

    Original URL path: http://www.nextechinvest.com/en/team/k-altmann.html (2016-04-26)
    Open archived version from archive

  • Team | P Greenberg | Nextechinvest
    for Distinguished Research in Tumor Immunology for studies in the development and translation of adoptive T cell therapy of cancer Prof Greenberg is the scientific co founder of Juno Therapeutics and is a member of a number of honorary societies including the American Society of Clinical Investigation the American Association of Physicians the American Association for the Advancement of Science and the American College of Physicians Sitemap Sitemap Home About

    Original URL path: http://www.nextechinvest.com/en/team/p-greenberg.html (2016-04-26)
    Open archived version from archive

  • Team | W Kaelin | Nextechinvest
    Medicine USA and of the board of directors of the American Association for Cancer Research He is involved with advisory provision to several oncology companies Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland P 41 0 44 366 66 11 F 41 0 44 366 66 10 Newsletter Registration Please fill

    Original URL path: http://www.nextechinvest.com/en/team/w-kaelin.html (2016-04-26)
    Open archived version from archive

  • Team | S Ponder | Nextechinvest
    both in Cambridge and founding Director of the new Cancer Research UK Cambridge Research Institute He is a fellow of such bodies as the Royal Society of London and the Royal College of Physicians and serves as a consultant to various oncology companies Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland

    Original URL path: http://www.nextechinvest.com/en/team/s-ponder.html (2016-04-26)
    Open archived version from archive

  • Team | C Sawyers | Nextechinvest
    Board of Scientific Councilors and is a member of the Institute of Medicine and the National Academy of Sciences He is a co founder of Agensys Inc and involved with advisory provision to several oncology companies Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland P 41 0 44 366 66 11

    Original URL path: http://www.nextechinvest.com/en/team/c-sawyers.html (2016-04-26)
    Open archived version from archive

  • Team | P Workman | Nextechinvest
    world s largest academic cancer drug discovery centre Paul has been elected a Fellow of the Academy of Medical Sciences Fellow of the Royal Society of Medicine Fellow of the Society of Biology Fellow of the Royal Society of Chemistry and Fellow of the European Academy of Cancer Sciences He was formerly Biology Section Head of Cancer Research AstraZeneca Ltd He was also the scientific founder of two oncology companies Piramed Pharma acquired by Roche and Chroma Therapeutics and has served as a consultant to many others Paul has won a number of awards for his discovery and development of new cancer drugs including PI3 kinase and HSP90 inhibitors He is a Cancer Research UK Life Fellow and winner of the 2010 Royal Society of Chemistry George and Christine Sosnovsky Award for Cancer Therapy and the 2012 Royal Society of Chemistry World Entrepreneur of the Year Award Paul is the leader of the teams that received the 2012 American Association of Cancer Research Team Science Award and the 2013 Cancer Research UK Translational Cancer Research Prize In 2014 Paul received the international Raymond Bourgine Award for excellence in cancer research Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy

    Original URL path: http://www.nextechinvest.com/en/team/p-workman.html (2016-04-26)
    Open archived version from archive

  • Team | K Wucherpfennig | Nextechinvest
    and Professor of Neurology at Harvard Medical School Prof Wucherpfennig s research focuses on the discovery of genes that control the activity of cytotoxic T cells in the tumor microenvironment drawing insights for the development of next generation cancer immunotherapies He has received a number of honors and awards including his election as a Fellow in the American Society for the Advancement of Science his election as a member of the Henry Kunkel Society at Rockefeller University and his election as a member of the American Society for Clinical Investigation He received his MD and PhD degrees from the University of Goettingen and completed post doctoral work in immunology at Brigham Women s Hospital Harvard Medical School and Harvard College Wucherpfennig serves as an advisor to a number of immuno oncology companies and since 2015 is an exclusive scientific consultant of Nextech Invest Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland P 41 0 44 366 66 11 F 41 0 44 366 66 10 Newsletter Registration Please fill in the subscription form completely If you wish to modify your personal

    Original URL path: http://www.nextechinvest.com/en/team/k-wucherpfennig.html (2016-04-26)
    Open archived version from archive